Chronic complete spinal cord injury remains a major challenge in regenerative neurobiology due to the formation of an inhibitory microenvironment that limits spontaneous axonal regeneration. This study aimed to evaluate the effectiveness of a sequential three-phase therapeutic strategy combining modulation of glial scarring, neurotrophic stimulation of axonal growth, and brain-computer interface-controlled neuromodulation for motor recovery after chronic spinal cord injury. The study involved 69 male Sprague-Dawley rats with complete spinal cord transection at the T9–T10 thoracic level. After an eight-week period for the development of chronic spasticity, the animals were allocated to standard rehabilitation (n=13), Phase I (n=14), Phase I+II (n=15), Phase I+II+III (n=14), or Phase III only (n=13). Functional, electrophysiological, molecular, and histological outcomes were assessed over 24 weeks. The complete protocol led to a 50.2% reduction in pathological reflex responses and an improved locomotor function to 13.7 points, representing a 15.2-fold increase compared with controls. The regenerating axon density increased 7.8 times, the synaptic density 5.8 times, and reinnervated motor units 17.9 times. Neurotrophic factors increased 3.3–3.7 times, while pro-inflammatory cytokines decreased by 52%. The full protocol was also associated with ectopic sprouting (2.4±1.1 points) and a lower mechanical withdrawal threshold (2.1±0.5 g), indicating greater mechanical hypersensitivity. Regression analysis showed that 91% of the functional recovery variability was explained by structural and molecular predictors. The findings suggest an improved locomotor recovery with sequential multimodal treatment in this rat model, while the safety findings and lack of large-animal validation limit direct clinical extrapolation.
Grillner S, El Manira A. Current principles of motor control, with special reference to vertebrate locomotion. Physiol Rev. 2020;100(1):271-320. doi:10.1152/physrev.00015.2019
Minassian K, Bayart A, Lackner P, Binder H, Freundl B, Hofstoetter US. Rare phenomena of central rhythm and pattern generation in a case of complete spinal cord injury. Nat Commun. 2023;14(1):3276. doi:10.1038/s41467-023-39034-y
Głowacka A, Ji B, Szczepankiewicz AA, Skup M, Gajewska-Woźniak O. BDNF spinal overexpression after spinal cord injury partially protects soleus neuromuscular junction from disintegration, increasing VAChT and AChE transcripts in soleus but not tibialis anterior motoneurons. Biomedicines. 2022;10(11):2851. doi:10.3390/biomedicines10112851
Grycz K, Głowacka A, Ji B, et al. Regulation of perineuronal net components in the synaptic bouton vicinity on lumbar α-motoneurons in the rat after spinalization and locomotor training: new insights from spatio-temporal changes in gene, protein expression and WFA labeling. Exp Neurol. 2022;354:114098. doi:10.1016/j.expneurol.2022.114098
Mazzone GL, Mohammadshirazi A, Aquino JB, Nistri A, Taccola G. GABAergic mechanisms can redress the tilted balance between excitation and inhibition in damaged spinal networks. Mol Neurobiol. 2021;58(8):3769-3786. doi:10.1007/s12035-021-02370-5
Beverungen H, Klaszky SC, Klaszky M, Côté MP. Rehabilitation decreases spasticity by restoring chloride homeostasis through the Brain-Derived Neurotrophic Factor-KCC2 pathway after spinal cord injury. J Neurotrauma. 2020;37(6):846-859. doi:10.1089/neu.2019.6526
Wincek A, Huber J, Leszczyńska K, et al. The long-term effect of treatment using the transcranial magnetic stimulation rTMS in patients after incomplete cervical or thoracic spinal cord injury. J Clin Med. 2021;10(13):2975. doi:10.3390/jcm10132975
Hettiaratchi MH, O’Meara MJ, O’Meara TR, Pickering AJ, Letko-Khait N, Shoichet MS. Reengineering biocatalysts: computational redesign of chondroitinase ABC improves efficacy and stability. Sci Adv. 2020;6(34):eabc6378. doi:10.1126/sciadv.abc6378
Giraldo E, Nebot VJ, Đorđević S, et al. A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury. Biomaterials. 2021;276:121052. doi:10.1016/j.biomaterials.2021.121052
Weidner N, Abel R, Maier D, et al. Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial. Lancet Neurol. 2025;24(1):42-53. doi:10.1016/S1474-4422(24)00447-2
Zawadzka M, Kwaśniewska A, Miazga K, Sławińska U. Perspectives in the cell-based therapies of various aspects of the spinal cord injury-associated pathologies: lessons from the animal models. Cells. 2021;10(11):2995. doi:10.3390/cells10112995
Rowald A, Komi S, Demesmaeker R, et al. Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis. Nat Med. 2022;28(2):260-271. doi:10.1038/s41591-021-01663-5
Lorach H, Galvez A, Spagnolo V, et al. Walking naturally after spinal cord injury using a brain-spine interface. Nature. 2023;618:126-133. doi:10.1038/s41586-023-06094-5
Kourgiantaki A, Tzeranis DS, Karali K, et al. Neural stem cell delivery via porous collagen scaffolds promotes neuronal differentiation and locomotion recovery in spinal cord injury. NPJ Regen Med. 2020;5(1):12. doi:10.1038/s41536-020-0097-0
Bhowmick S, Muneer PMA. PTEN blocking stimulates corticospinal and raphespinal axonal regeneration and promotes functional recovery after spinal cord injury. J Neuropathol Exp Neurol. 2021;80(2):169-181. doi:10.1093/jnen/nlaa147
Griffin JM, Bradke F. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med. 2020;12(3):e11505. doi:10.15252/emmm.201911505
Babaeva R. Neuron structure of the ganglion plexuses in the large intestine. Arch Euromed. 2021;11(4):45-47. doi:10.35630/2199-885X/2021/11/4.11
Das S, Tolibov D, Mirzaeva D, Baratovna DZ, Dinmukhammadieva D. Outcomes of neuromuscular retraining and adjunctive electrical stimulation in Bell’s palsy: A single-centre observational cohort study. Acta Neurol Belg. Published online 2026. doi:10.1007/s13760-026-03166-x
Pedrini FA, Boriani F, Bolognesi F, Fazio N, Marchetti C, Baldini N. Cell-enhanced acellular nerve allografts for peripheral nerve reconstruction: A systematic review and a meta-analysis of the literature. Neurosurgery. 2019;85(5):575-604. doi:10.1093/neuros/nyy374
Sconza C, Negrini F, Di Matteo B, et al. Robot-assisted gait training in patients with multiple sclerosis: A randomized controlled crossover trial. Medicina (Kaunas). 2021;57(7):713. doi:10.3390/medicina57070713
Yrysov K, Tashibekov J. Results of diagnosis and surgical treatment of spinal cord injury. Euroasian Health J. 2024;16(3):163-171. doi:10.54890/1694-8882-2024-3-163
Chaulagain D. Surgical treatment of lumbar prolapsed intervertebral disc (PIVD): A comprehensive review comparing conventional microdiscectomy versus endoscopic discectomy – emphasis on recurrence rates. J Hum Biol Clin Med. 2026;2(2):32-42. doi:10.63621/jhbcm/2.2026.32
Bolcato M, Feola A, Sanavio M, et al. The state of knowledge of young Italian medicolegal doctors on the law of provisions for informed consent and advance treatment directives: A multi-centric survey two years after the enactment of Law 219 of 2017. Acta Biomed. 2020;92(1):e2021005. doi:10.23750/abm.v92i1.10129
Messina A, Crescimanno C, Cuccì G, Caraci F, Signorelli MS. Cell adhesion molecules in the pathogenesis of the schizophrenia. Folia Med (Plovdiv). 2023;65(5):707-712. doi:10.3897/folmed.65.e101356
Sagymbayev M, Koichubekov A, Rahmanov B. Recovery treatment in the intermediate and late periods of spinal cord injury. Euroasian Health J. 2024;16(4):168-172. doi:10.54890/1694-8882-2024-4-168
Boakye M, Ball T, Dietz N, et al. Spinal cord epidural stimulation for motor and autonomic function recovery after chronic spinal cord injury: A case series and technical note. Surg Neurol Int. 2023;14:87. doi:10.25259/SNI_1074_2022
Hachmann JT, Yousak A, Wallner JJ, Gad PN, Edgerton VR, Gorgey AS. Epidural spinal cord stimulation as an intervention for motor recovery after motor complete spinal cord injury. J Neurophysiol. 2021;126(6):1843-1859. doi:10.1152/jn.00020.2021
Levett JJ, Elkaim LM, Niazi F, et al. Invasive brain computer interface for motor restoration in spinal cord injury: a systematic review. Neuromodulation Technol Neural Interface. 2024;27(4):597-603. doi:10.1016/j.neurom.2023.10.006
Khanteymoori A, Peterson C, Atamny R, et al. Targeting nerve fiber outgrowth inhibition after experimental spinal cord injury: A systematic review and meta-analysis of chondroitinase ABC. Neurorehabil Neural Repair. 2025;39(4):312-320. doi:10.1177/15459683241311337
Maynard G, Kannan R, Liu J, et al. Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial. Lancet Neurol. 2023;22(8):672-684. doi:10.1016/S1474-4422(23)00215-6
O’Shea TM, Ao Y, Wang S, et al. Derivation and transcriptional reprogramming of border-forming wound repair astrocytes after spinal cord injury or stroke in mice. Nat Neurosci. 2024;27(8):1505-1521. doi: 10.1038/s41593-024-01684-6
Burda JE, O’Shea TM, Ao Y, et al. Divergent transcriptional regulation of astrocyte reactivity across disorders. Nature. 2022;606(7914):557-564. doi:10.1038/s41586-022-04739-5
Martin KK, Noble DJ, Parvin S, Jang K, Garraway SM. Pharmacogenetic inhibition of TrkB signaling in adult mice attenuates mechanical hypersensitivity and improves locomotor function after spinal cord injury. Front Cell Neurosci. 2022;16:987236. doi:10.3389/fncel.2022.987236
Rosner J, de Andrade DC, Davis KD, et al. Central neuropathic pain. Nat Rev Dis Primers. 2023;9(1):73. doi:10.1038/s41572-023-00484-9
Metcalfe M, Steward O. PTEN deletion in spinal pathways via retrograde transduction with AAV-RG enhances forelimb motor recovery after cervical spinal cord injury; Sex differences and late-onset pathophysiologies. Exp Neurol. 2023;370:114551. doi:10.1016/j.expneurol.2023.114551
Dhaliwal NK, Weng OY, Dong X, et al. Synergistic hyperactivation of both mTORC1 and mTORC2 underlies the neural abnormalities of PTEN-deficient human neurons and cortical organoids. Cell Rep. 2024;43(5):114173. doi:10.1016/j.celrep.2024.114173
Verdera HC, Kuranda K, Mingozzi F. AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol Ther. 2020;28(3):723-746. doi:10.1016/j.ymthe.2019.12.010
Bharucha-Goebel DX, Todd JJ, Saade D, et al. Intrathecal gene therapy for giant axonal neuropathy. N Engl J Med. 2024;390(12):1092-1104. doi:10.1056/NEJMoa2307952
Bilchak JN, Yeakle K, Caron G, Malloy D, Côté MP. Enhancing KCC2 activity decreases hyperreflexia and spasticity after chronic spinal cord injury. Exp Neurol. 2021;338:113605. doi:10.1016/j.expneurol.2021.113605
Álvarez Z, Kolberg-Edelbrock AN, Sasselli IR, et al. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science. 2021;374(6569):848-856. doi:10.1126/science.abh3602
Pandini S, Riccò T, Borboni A, et al. Tailored one-way and two-way shape memory capabilities of poly(ε-caprolactone)-based systems for biomedical applications. J Mater Eng Perform. 2014;23(7):2545-2552. doi:10.1007/s11665-014-1033-5
Pesel G, Ricci G, Gibelli F, Sirignano A. Electronic unified therapy record as a clinical risk management tool in the Italian healthcare system. Front Public Health. 2022;10:919543. doi:10.3389/fpubh.2022.919543
Jeffery ND, Brakel K, Aceves M, Hook MA, Jeffery UB. Variability in open-field locomotor scoring following force-defined spinal cord injury in rats: quantification and implications. Front Neurol. 2020;11:650. doi:10.3389/fneur.2020.00650
Garcia-Ramirez DL, Ha NT, Bibu S, Stachowski NJ, Dougherty KJ. Spinal cord injury alters spinal shox2 interneurons by enhancing excitatory synaptic input and serotonergic modulation while maintaining intrinsic properties in mouse. J Neurosci. 2021;41(27):5833-5848. doi:10.1523/jneurosci.1576-20.2021
Stachowski NJ, Wheel JH, Singh S, et al. Activity of spinal RORβ neurons is related to functional improvements following combination treatment after complete SCI. Proc Natl Acad Sci. 2025;122(15):e2406333122. doi:10.1073/pnas.2406333122
Calvert JS, Parker SR, Govindarajan LN, et al. Perilesional neuromodulation replaces lost sensorimotor function in persons with spinal cord injury. Nat Biomed Eng. Published online 2026. doi:10.1038/s41551-026-01627-5
Kitagawa T, Nagoshi N, Kamata Y, et al. Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury. Stem Cell Rep. 2022;17(1):127-142. doi:10.1016/j.stemcr.2021.12.005
Yao X, Zhang K, Na T, et al. Human iPSC-derived spinal neural progenitors enhance sensorimotor recovery in spinal cord-injured NOD-SCID mice via differentiation and microenvironment regulation. Cell Death Dis. 2025;16(1):637. doi:10.1038/s41419-025-07961-x
Zuo Y, Ye J, Cai W, et al. Controlled delivery of a neurotransmitter-agonist conjugate for functional recovery after severe spinal cord injury. Nat Nanotechnol. 2023;18(10):1230-1240. doi:10.1038/s41565-023-01416-0
Wang Y, Liu F, Shan Q, et al. Functional recovery induced by KCC2-enabled relay pathways in completely injured spinal cords in adult rats. Proc Natl Acad Sci. 2025;122(50):e2421823122. doi:10.1073/pnas.2421823122
Chen B, Gaikwad S, Powell RH, et al. Combinatorial approaches increasing neuronal activity accelerate recovery after spinal cord injury. Brain. 2025;148(6):1911-1923. doi:10.1093/brain/awaf099

This work is licensed under a Creative Commons Attribution 4.0 International License.